<DOC>
	<DOCNO>NCT02147184</DOCNO>
	<brief_summary>Building finding animal study , pediatric clinical trial , epidemiologic research adult , preliminary finding investigator ' laboratory child adolescent , project aim investigate whether selective serotonin reuptake inhibitor ( SSRIs ) , group widely-used psychotropics , associate impaired bone mineralization youth . Establishing association first step process would eventually involve develop preventative intervention . Identifying genetic factor place certain youth higher risk side effect would ultimately allow clinician tailor treatment need vulnerability youth , move field closer towards individualize medicine .</brief_summary>
	<brief_title>Do Serotonin Reuptake Inhibitors ( SSRIs ) Affect Bone Mass Adolescents</brief_title>
	<detailed_description>Bone mass achieve early adulthood major determinant lifetime risk osteoporosis . Therefore , optimize peak bone mass crucial avoid bone fracture associate morbidity mortality . Emerging evidence suggest serotonin plays central role bone metabolism . For example , preclinical experiment show bone cell express serotonin transporter variety functional serotonin receptor whose activity modulate bone turnover . Epidemiologic study link SSRIs reduce bone mineral density increase fracture risk elderly . SSRIs widely use youth treat number psychiatric disorder . However , short-term efficacy safety establish , long-term safety remain little investigated . The investigator aim recruit , 2-year prospective observational study , 15 20 year-old participant upon initiation SSRI treatment . During study period , bone mineral density lumbar spine whole body measure use dual-energy x-ray absorptiometry ( DXA ) radius use peripheral quantitative compute tomography ( pQCT ) . A detailed psychiatric assessment conduct control psychopathology , potential confounding factor affect bone mineralization . Changes psychiatric treatment follow period also document account . By use group control , comparable age sex distribution , investigator aim evaluate 1 ) whether psychopathology , baseline , associate low bone mass , 2 ) treatment SSRIs suppress bone mineralization , 3 ) discontinuation SSRI follow restoration bone mineral accrual . 4 ) Furthermore , genetic test investigate whether variant serotonin system gene moderate effect SSRI treatment bone mineral density . In sum , work aim improve long-term safety psychiatric treatment order optimize function quality life suffer psychiatric disorder .</detailed_description>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>1 . Age 15 20 year old ( inclusive ) . 2 . Treatment SSRI , regardless indication , start within one month . This criterion apply control . SSRIs include : fluoxetine , citalopram , escitalopram , sertraline , paroxetine , fluvoxamine . 3 . Ability provide consent . 1 . Age sexadjusted height Zscore &lt; 2 &gt; 2 . 2 . Concomitant treatment antidepressant , psychostimulants , mood stabilizer antipsychotic . Treatment benzodiazepine , low dose trazodone , alpha2 agonist , antihistaminergic agent allow . 3 . Presence illicit drug and/or alcohol dependence . 4 . Pregnancy . 5 . Primary bone disease ( e.g. , Paget 's disease , osteogenesis imperfecta , rheumatoid arthritis ) . 6 . Potential secondary bone disease ( e.g. , due chronic inflammatory disease , diabetes , hypo hyperparathyroidism , hyperthyroidism , growth hormone deficiency , endocrine disturbance , history childhood cancer , prior transplantation ) . 7 . Chronic disorder involve vital organ ( heart , lung , liver , kidney , brain ) congenital disorder . 8 . Malnutrition condition ( e.g. , chronic diarrhea , inflammatory bowel disease ) lead poison . 9 . Chronic use drug affect bone metabolism ( e.g. , oral corticosteroid ) . 10 . Inability cooperate BMD measurement . 11 . Eating disorder , due potential effect BMD . 12 . If senior high school , plan join outofstate college .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>SSRI</keyword>
	<keyword>serotonin transporter</keyword>
	<keyword>DXA</keyword>
	<keyword>pQCT</keyword>
	<keyword>bone mass</keyword>
	<keyword>adolescent</keyword>
</DOC>